Notice2022-10990
Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 23, 2022
Issuing agencies
Health and Human Services Department
Abstract
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The meeting will be open to the public; a pre-registered public comment session will be held during the meeting. Pre-registration is required for members of the public who wish to attend the meeting and who wish to participate in the public comment session. Individuals who wish to attend the meeting and/or send in their public comment via email should send an email to CARB@hhs.gov. Registration information is available on the website http://www.hhs.gov/paccarb and must be completed by September 5, 2022; all in-person attendees must pre-register by this date and will be given priority over unregistered attendees. Additional information about any updates to COVID-19 safety precautions or requirements, including how to register for the meeting and provide public comment, can be obtained at http://www.hhs.gov/paccarb on the Meetings page. Please visit the page for frequent updates.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 99 (Monday, May 23, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 99 (Monday, May 23, 2022)]
[Notices]
[Pages 31245-31246]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-10990]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that a meeting is scheduled to be held for the Presidential Advisory
Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The
meeting will be open to the public; a pre-registered public comment
session will be held during the meeting. Pre-registration is required
for members of the public who wish to attend the meeting and who wish
to participate in the public comment session. Individuals who wish to
attend the meeting and/or send in their public comment via email should
send an email to <a href="/cdn-cgi/l/email-protection#94d7d5c6d6d4fcfce7baf3fbe2"><span class="__cf_email__" data-cfemail="eaa9abb8a8aa828299c48d859c">[email protected]</span></a>. Registration information is available on
the website <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> and must be completed by
September 5, 2022; all in-person attendees must pre-register by this
date and will be given priority over unregistered attendees. Additional
information about any updates to COVID-19 safety precautions or
requirements, including how to register for the meeting and provide
public comment, can be obtained at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> on the
Meetings page. Please visit the page for frequent updates.
DATES: The meeting is tentatively scheduled to be held on September 12,
from 9:00 a.m. to 5:00 p.m., and September 13, 2022, from 9:00 a.m. to
5:00 p.m. ET (all times are subject to change). The confirmed times and
agenda items for the meeting will be posted on the website for the
PACCARB at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> when this information becomes
available. Pre-registration for attending the meeting in person is
required to be completed no later than September 5, 2022; public
attendance at the meeting is limited to the available space.
ADDRESSES: Tysons Corner Marriott, 8028 Leesburg Pike, Tysons Corner,
Virginia 22182. The meeting can also be accessed through a live webcast
and via teleconference on the day of the meeting. For more information,
visit <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, Room L616, Switzer Building,
330 C St. SW, Washington, DC 20201. Email: <a href="/cdn-cgi/l/email-protection#783b392a3a3810100b561f170e"><span class="__cf_email__" data-cfemail="3d7e7c6f7f7d55554e135a524b">[email protected]</span></a>. Telephone:
(202) 746-1512.
SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria (PACCARB), established by
Executive Order 13676, is continued by Section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and duties of the Advisory Council
are governed by the provisions of the Federal Advisory Committee Act
(FACA), Public Law 92-463, as amended (5 U.S.C. App.), which sets forth
standards for the formation and use of federal advisory committees.
The PACCARB shall advise and provide information and
recommendations to the Secretary regarding programs and policies
intended to reduce or combat antibiotic-resistant bacteria that may
present a public health threat and improve capabilities to prevent,
diagnose, mitigate, or treat such resistance. The PACCARB shall
function solely for advisory purposes.
Such advice, information, and recommendations may be related to
improving: The effectiveness of antibiotics; research and advanced
research on, and the development of, improved and innovative methods
for combating or reducing antibiotic resistance, including new
treatments, rapid point-of-care diagnostics, alternatives to
antibiotics, including alternatives to animal antibiotics, and
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health
care providers and the public with respect to up-to-date information on
antibiotic resistance and ways to reduce or combat such resistance to
antibiotics related to humans and animals; methods to prevent or reduce
the transmission of antibiotic-resistant bacterial infections;
including stewardship programs; and coordination with respect to
international efforts in order to inform and advance the United States
capabilities to combat antibiotic resistance.
The September 12-13, 2022 public meeting will be dedicated to a One
Health AMR and Pandemic Preparedness Policy Workshop with the goal of
identifying key issues and critical policy gaps through a series of
facilitated discussions examining a hypothetical large-scale disease
outbreak scenario based on historic examples and estimates of future
AMR
[[Page 31246]]
outbreaks. The meeting agenda will be posted on the PACCARB website at
<a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> when it has been finalized. All agenda items
are tentative and subject to change.
Public attendance at the meeting is limited to the available space.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the PACCARB by emailing <a href="/cdn-cgi/l/email-protection#2d6e6c7f6f6d45455e034a425b"><span class="__cf_email__" data-cfemail="eaa9abb8a8aa828299c48d859c">[email protected]</span></a> at least one week prior to
the meeting. For those unable to attend in person, a live webcast will
be available. More information on registration and accessing the
webcast can be found at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>.
Members of the public will have the opportunity to provide comments
during and prior to the PACCARB meeting by indicating their preference
in their registration available on the PACCARB website at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a> and/or by emailing <a href="/cdn-cgi/l/email-protection#a1e2e0f3e3e1c9c9d28fc6ced7"><span class="__cf_email__" data-cfemail="1350524151537b7b603d747c65">[email protected]</span></a>. Public comments
can also be sent in by mail, and if so, correspondence should be sent
in by midnight September 5, 2022, and should be limited to no more than
one page. All public comments received prior to September 5, 2022, will
be provided to PACCARB members. Additionally, companies and/or
organizations involved in combating antibiotic resistance have an
opportunity to present their work to members of the PACCARB during an
Innovation Spotlight. Pre-registration is required for participation,
with limited spots available. All information regarding this session
can also be found online at <a href="http://www.hhs.gov/paccarb">http://www.hhs.gov/paccarb</a>.
Dated: May 13, 2022.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for
Health.
[FR Doc. 2022-10990 Filed 5-20-22; 8:45 am]
BILLING CODE 4150-44-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 23, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.